What top creators are saying about BioStem Technologies(BSEM)

Company producing a wound care dressing from placentas with an extremely high gross margin.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about BioStem Technologies in the last 30 days yet.

Top creators covering BioStem Technologies (BSEM)

The 1 sources with the most insights about BioStem Technologies on Kazuha.

Latest insights about BioStem Technologies (BSEM)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Wednesday, July 16, 2025

Bullish
Target: 5x to 10x multi-bagger potential

An asymmetric, high-risk/high-reward bet. The stock is extremely cheap (P/S of 0.5) but faces a significant risk of losing Medicare reimbursement. Potential catalysts include a NASDAQ uplisting and a positive CMS decision, which could lead to a 5x to 10x return.

Friday, June 27, 2025

Bearish

Mentioned as being even cheaper than CoreMedix, but it carries a major 'binary risk' due to the potential loss of Medicare reimbursement in 2026, which could be catastrophic for the company.

Discussed alongside BioStem Technologies (BSEM)

Other assets that creators frequently mention in the same content as BioStem Technologies.

Frequently asked

Which podcasters and creators cover BioStem Technologies (BSEM) the most?

The most active sources covering BioStem Technologies (BSEM) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about BioStem Technologies (BSEM) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about BioStem Technologies (BSEM) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside BioStem Technologies (BSEM)?

Creators covering BioStem Technologies (BSEM) most frequently also discuss CRMD, DVA, HIMS, KULR, DCTH. See the "Discussed alongside" section above for full asset pages.